東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁 到查詢結果 [ null ]

切換: 標籤 | MARC模式 | ISBD

Transcriptional Regulation of Fate S...

Kwon, Nayoung,

FindBook

Google Book

Amazon

博客來

Transcriptional Regulation of Fate Specification in Human Megakaryocytic-Erythroid Progenitors /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Transcriptional Regulation of Fate Specification in Human Megakaryocytic-Erythroid Progenitors // Nayoung Kwon.
作者:	Kwon, Nayoung,
面頁冊數:	1 electronic resource (115 pages)
附註:	Source: Dissertations Abstracts International, Volume: 86-01, Section: B.
Contained By:	Dissertations Abstracts International86-01B.
標題:	Cellular biology. -
電子資源:	https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30995393
ISBN:	9798383482261

Transcriptional Regulation of Fate Specification in Human Megakaryocytic-Erythroid Progenitors /
Kwon, Nayoung,

Transcriptional Regulation of Fate Specification in Human Megakaryocytic-Erythroid Progenitors /Nayoung Kwon. - 1 electronic resource (115 pages)

Source: Dissertations Abstracts International, Volume: 86-01, Section: B.

Megakaryocytic-erythroid progenitors (MEP) are a population of bipotent hematopoietic progenitors that give rise to the megakaryocytic (Mk) or erythroid (E) lineages. The Mk lineage produces platelets, and the E lineage produces RBCs, that govern coagulation and oxygen transport, respectively. Both are critical components of the blood system, and maintaining an adequate and balanced pool of platelets and red blood cells is essential for life. As MEP stand as a final branchpoint before committing to Mk or E lineages, understanding the fate specification mechanism of MEP may provide insight into treating conditions that involve platelets and/or red blood cells.This thesis focuses on elucidating the role of selected transcription factors in the MEP fate specification process. Chapter 3 focuses on RUNX1 and shows that RUNX1 promotes Mk fate in MEP. This function is enhanced by serine/threonine phosphorylation of RUNX1. Phosphoserine-RUNX1 levels are highest in the Mk lineage compared to MEP or the E lineage while neither RUNX1 mRNA nor total protein levels differ between Mk and E committed progenitors. RUNX1 mutants that are non-phosphorylatable (RUNX1-4A) or phosphomimetic (RUNX1-4D) were tested for their effects on MEP fate specification and in the HEL cell line, a leukemic cell line that models MEP. It was found that the phosphomimetic mutant form of RUNX1 was more potent in inducing Mk fate in MEP and mature Mk signatures in HEL cell line than RUNX1-WT or the non-phosphorylatable mutant. Differential gene expression patterns induced by WT and mutant forms of RUNX1 were also explored in HEL cells, and the changes in gene expression were consistent with the observed phenotypes. The mechanism underlying RUNX1 phosphorylation in MEP was also explored, and CDK9 was discovered to be at least one of the kinases that phosphorylates RUNX1 in MEP. CDK9 inhibition affected MEP fate by promoting E fate specification.Chapters 4 and 5 are focused on the potential roles of NR4A1, MYB, and MYBL2 in MEP fate specification. While an effect of NR4A1 on MEP fate specification was not evident, NR4A1 potentially showed an as yet unexplored role in promoting Mk maturation. NR4A1 KD in CD34+ HSPC resulted in a decrease of polyploidization of maturing megakaryocytes. MYB KD promotes Mk fate, and MYBL2 KD inhibits colony formation. Neither MYB nor MYBL2 OE had reproducible effects on MEP fate specification. However, comparison of the binding sites of MYB and MYBL2 in K562 cells (n=1) revealed that MYB may bind to the promoter regions of some genes that are essential for erythropoiesis, which potentially explains KD of MYB promoting Mk fate. By enrichment analysis, genomic targets that were associated with MYB but not with MYBL2 were enriched for RNA splicing machinery genes, and genomic targets that were associated with MYBL2 but not with MYB were enriched for cell cycle machinery genes. Binding sites shared by MYB and MYBL2 also revealed some interesting target genes, including transcription factors and epigenetic regulators.Transcription factors work collectively to direct the fate specification of MEP. The work presented in thesis strongly suggests that RUNX1 is part of this network. While other investigated transcription factors (NR4A1, MYB, MYBL2) showed less of an effect on MEP fate specification, they play essential roles in the hematopoietic system and the data presented in this thesis will provide a basis for future studies.

English

ISBN: 9798383482261Subjects--Topical Terms:

3172791
Cellular biology.
Subjects--Index Terms:

Megakaryocytic-erythroid progenitors

Transcriptional Regulation of Fate Specification in Human Megakaryocytic-Erythroid Progenitors /
LDR:04849nmm a22003853i 4500 001 2428442
005 20250410083500.5
006 m o d
007 cr|nu||||||||
008 261011s2024 miu||||||m |||||||eng d
020 $a 9798383482261
035 $a (MiAaPQD)AAI30995393
035 $a AAI30995393
040 $a MiAaPQD $b eng $c MiAaPQD $e rda
100 1 $a Kwon, Nayoung, $e author. $3 3815656
245 1 0 $a Transcriptional Regulation of Fate Specification in Human Megakaryocytic-Erythroid Progenitors / $c Nayoung Kwon.
264 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2024
300 $a 1 electronic resource (115 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertations Abstracts International, Volume: 86-01, Section: B.
500 $a Advisors: Krause, Diane S. Committee members: Guo, Shangqin; Greco, Valentina; Stern, David F.
502 $b Ph.D. $c Yale University $d 2024.
520 $a Megakaryocytic-erythroid progenitors (MEP) are a population of bipotent hematopoietic progenitors that give rise to the megakaryocytic (Mk) or erythroid (E) lineages. The Mk lineage produces platelets, and the E lineage produces RBCs, that govern coagulation and oxygen transport, respectively. Both are critical components of the blood system, and maintaining an adequate and balanced pool of platelets and red blood cells is essential for life. As MEP stand as a final branchpoint before committing to Mk or E lineages, understanding the fate specification mechanism of MEP may provide insight into treating conditions that involve platelets and/or red blood cells.This thesis focuses on elucidating the role of selected transcription factors in the MEP fate specification process. Chapter 3 focuses on RUNX1 and shows that RUNX1 promotes Mk fate in MEP. This function is enhanced by serine/threonine phosphorylation of RUNX1. Phosphoserine-RUNX1 levels are highest in the Mk lineage compared to MEP or the E lineage while neither RUNX1 mRNA nor total protein levels differ between Mk and E committed progenitors. RUNX1 mutants that are non-phosphorylatable (RUNX1-4A) or phosphomimetic (RUNX1-4D) were tested for their effects on MEP fate specification and in the HEL cell line, a leukemic cell line that models MEP. It was found that the phosphomimetic mutant form of RUNX1 was more potent in inducing Mk fate in MEP and mature Mk signatures in HEL cell line than RUNX1-WT or the non-phosphorylatable mutant. Differential gene expression patterns induced by WT and mutant forms of RUNX1 were also explored in HEL cells, and the changes in gene expression were consistent with the observed phenotypes. The mechanism underlying RUNX1 phosphorylation in MEP was also explored, and CDK9 was discovered to be at least one of the kinases that phosphorylates RUNX1 in MEP. CDK9 inhibition affected MEP fate by promoting E fate specification.Chapters 4 and 5 are focused on the potential roles of NR4A1, MYB, and MYBL2 in MEP fate specification. While an effect of NR4A1 on MEP fate specification was not evident, NR4A1 potentially showed an as yet unexplored role in promoting Mk maturation. NR4A1 KD in CD34+ HSPC resulted in a decrease of polyploidization of maturing megakaryocytes. MYB KD promotes Mk fate, and MYBL2 KD inhibits colony formation. Neither MYB nor MYBL2 OE had reproducible effects on MEP fate specification. However, comparison of the binding sites of MYB and MYBL2 in K562 cells (n=1) revealed that MYB may bind to the promoter regions of some genes that are essential for erythropoiesis, which potentially explains KD of MYB promoting Mk fate. By enrichment analysis, genomic targets that were associated with MYB but not with MYBL2 were enriched for RNA splicing machinery genes, and genomic targets that were associated with MYBL2 but not with MYB were enriched for cell cycle machinery genes. Binding sites shared by MYB and MYBL2 also revealed some interesting target genes, including transcription factors and epigenetic regulators.Transcription factors work collectively to direct the fate specification of MEP. The work presented in thesis strongly suggests that RUNX1 is part of this network. While other investigated transcription factors (NR4A1, MYB, MYBL2) showed less of an effect on MEP fate specification, they play essential roles in the hematopoietic system and the data presented in this thesis will provide a basis for future studies.
546 $a English
590 $a School code: 0265
650 4 $a Cellular biology. $3 3172791
653 $a Megakaryocytic-erythroid progenitors
653 $a MEP fate specification
653 $a Transcription factors
690 $a 0379
710 2 $a Yale University. $b Cell Biology. $e degree granting institution. $3 3815657
720 1 $a Krause, Diane S. $e degree supervisor.
773 0 $t Dissertations Abstracts International $g 86-01B.
790 $a 0265
791 $a Ph.D.
792 $a 2024
856 4 0 $u https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30995393